Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Thyroid Neoplasms × Thyroxine × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 7 Observational 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1

Interventions

Thyroidectomy 5 Iodine-131 5 lenvatinib 2 anlotinib 2 Ultrasonography 2 Surgical Procedures, Operative 2 Sorafenib 2 Interviews as Topic 2 Focus Groups 2 Biopsy, Fine-Needle 2 trastuzumab deruxtecan 1 trametinib 1 selpercatinib 1 pralsetinib 1 pembrolizumab 1 gallium Ga 68 dotatate 1 dabrafenib 1 Triiodothyronine 1 Transurethral Resection of Prostate 1 Thyroxine 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Routinely Collected Health Data 1 Nivolumab 1 Molecular Diagnostic Techniques 1 Minimally Invasive Surgical Procedures 1 Lymph Node Excision 1 Iodine-124 1 Iodine-123 1 Immunohistochemistry 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06647602 2026-02-10

THRIVE

University Medical Center Groningen

Not yet recruiting

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡